Literature DB >> 16170369

Induction of cyclooxygenase-2 by benzo[a]pyrene diol epoxide through inhibition of retinoic acid receptor-beta 2 expression.

Shumei Song1, Scott M Lippman, Yiyu Zou, Xiaofeng Ye, Jaffer A Ajani, Xiao-Chun Xu.   

Abstract

Benzo[a]pyrene diol epoxide (BPDE, a carcinogen present in tobacco smoke and environmental pollution) has been shown to suppress retinoic acid receptor-beta2 (RAR-beta(2)) and induce cyclooxygenase-2 (COX-2) expression. Restoration of RAR-beta(2) inhibited growth and colony formation of esophageal cancer cells, which was correlated with COX-2 suppression. In this study, we investigated the molecular mechanisms for RAR-beta(2)-mediated suppression of COX-2 expression using BPDE as a tool. We found that BPDE-induced COX-2 expression was through inhibition of RAR-beta(2) and consequently, induction of epidermal growth factor receptor (EGFR), extracellular signal-regulated protein kinases 1/2 (Erk1/2) phosphorylation, and c-Jun expression. Esophageal cancer cells that do not express RAR-beta(2) did not respond to BPDE for induction of COX-2. BPDE was also unable to induce COX-2 expression after RAR-beta(2) expression was manipulated in these esophageal cancer cells. Furthermore, BPDE induced time-dependent methylation of RAR-beta(2) gene promoter in esophageal cancer cells. Transfection of RAR-beta(2) expression vector into esophageal cancer cells suppressed expression of EGFR, Erk1/2 phosphorylation, c-Jun, and COX-2. In addition, co-treatment of RAR-beta(2)-positive cells with BPDE and the MEK1/2 inhibitor U0126 caused little change in c-Jun and COX-2 expression. This study demonstrated that BPDE-suppressed expression of RAR-beta(2) results in COX-2 induction and restoration of RAR-beta(2) expression reduces COX-2 protein in esophageal cancer cells, thereby further supporting our previous finding that RAR-beta(2) plays an important role in suppressing esophageal carcinogenesis. Oncogene (2005) 24, 8268-8276. doi:10.1038/sj.onc.1208992; published online 19 September 2005.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16170369     DOI: 10.1038/sj.onc.1208992

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  23 in total

1.  Rapamycin-upregulated miR-29b promotes mTORC1-hyperactive cell growth in TSC2-deficient cells by downregulating tumor suppressor retinoic acid receptor β (RARβ).

Authors:  Heng-Jia Liu; Hilaire C Lam; Christian V Baglini; Julie Nijmeh; Alischer A Cottrill; Stephen Y Chan; Elizabeth P Henske
Journal:  Oncogene       Date:  2019-08-16       Impact factor: 9.867

Review 2.  Second-hand smoke and human lung cancer.

Authors:  Ahmad Besaratinia; Gerd P Pfeifer
Journal:  Lancet Oncol       Date:  2008-07       Impact factor: 41.316

3.  Human papillomavirus type 16 E7 oncoprotein upregulates the retinoic acid receptor-beta expression in cervical cancer cell lines and K14E7 transgenic mice.

Authors:  Jorge Gutiérrez; Enrique García-Villa; Rodolfo Ocadiz-Delgado; Enoc M Cortés-Malagón; Juan Vázquez; Alejandra Roman-Rosales; Elizabeth Alvarez-Rios; Haydar Celik; Marta C Romano; Aykut Üren; Paul F Lambert; Patricio Gariglio
Journal:  Mol Cell Biochem       Date:  2015-07-15       Impact factor: 3.396

4.  A novel all-trans retinoic acid derivative inhibits proliferation and induces differentiation of human gastric carcinoma xenografts via up-regulating retinoic acid receptor β.

Authors:  Jing Ju; Nan Wang; Xinqun Wang; Feihu Chen
Journal:  Am J Transl Res       Date:  2015-05-15       Impact factor: 4.060

Review 5.  Tumor-suppressive activity of retinoic acid receptor-beta in cancer.

Authors:  Xiao-Chun Xu
Journal:  Cancer Lett       Date:  2006-12-22       Impact factor: 8.679

6.  Epidermal growth factor receptor protein overexpression and gene amplification are associated with aggressive biological behaviors of esophageal squamous cell carcinoma.

Authors:  Gang Lin; Xiao-Jiang Sun; Qian-Bo Han; Zhun Wang; Ya-Ping Xu; Jia-Lei Gu; Wei Wu; G U Zhang; Jin-Lin Hu; Wen-Yong Sun; Wei-Min Mao
Journal:  Oncol Lett       Date:  2015-05-27       Impact factor: 2.967

7.  Benzo[a]pyrene diol epoxide suppresses retinoic acid receptor-beta2 expression by recruiting DNA (cytosine-5-)-methyltransferase 3A.

Authors:  Fei Ye; Xiao-Chun Xu
Journal:  Mol Cancer       Date:  2010-04-28       Impact factor: 27.401

8.  Inhibition of farnesoid X receptor controls esophageal cancer cell growth in vitro and in nude mouse xenografts.

Authors:  Baoxiang Guan; Hao Li; Zhengduo Yang; Ashraful Hoque; Xiaochun Xu
Journal:  Cancer       Date:  2012-12-20       Impact factor: 6.860

9.  Neu-164 and Neu-107, two novel antioxidant and anti-myeloperoxidase compounds, inhibit acute cigarette smoke-induced lung inflammation.

Authors:  Thomas H Thatcher; Hsi-Min Hsiao; Elhanan Pinner; Moshe Laudon; Stephen J Pollock; Patricia J Sime; Richard P Phipps
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2013-05-17       Impact factor: 5.464

10.  Identification of the B-Raf/Mek/Erk MAP kinase pathway as a target for all-trans retinoic acid during skin cancer promotion.

Authors:  Satish B Cheepala; Weihong Yin; Zanobia Syed; Jennifer N Gill; Alaina McMillian; Heather E Kleiner; Mark Lynch; Rasiah Loganantharaj; Marjan Trutschl; Urska Cvek; John L Clifford
Journal:  Mol Cancer       Date:  2009-05-11       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.